JCRRF
Price
$5.00
Change
+$1.22 (+32.28%)
Updated
Jul 18 closing price
Capitalization
501.49M
LYPHF
Price
$0.27
Change
+$0.01 (+3.85%)
Updated
Apr 11 closing price
Capitalization
1.67B
Interact to see
Advertisement

JCRRF vs LYPHF

Header iconJCRRF vs LYPHF Comparison
Open Charts JCRRF vs LYPHFBanner chart's image
JCR PHARMACEUTICALS
Price$5.00
Change+$1.22 (+32.28%)
Volume$680
Capitalization501.49M
Luye Pharma Group
Price$0.27
Change+$0.01 (+3.85%)
Volume$3.73K
Capitalization1.67B
JCRRF vs LYPHF Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JCRRF vs. LYPHF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCRRF is a Hold and LYPHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (JCRRF: $5.00 vs. LYPHF: $0.27)
Brand notoriety: JCRRF and LYPHF are both not notable
JCRRF represents the Pharmaceuticals: Major, while LYPHF is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: JCRRF: 142% vs. LYPHF: 100%
Market capitalization -- JCRRF: $501.49M vs. LYPHF: $1.67B
JCRRF [@Pharmaceuticals: Major] is valued at $501.49M. LYPHF’s [@Pharmaceuticals: Generic] market capitalization is $1.67B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $656.17B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $88.99B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JCRRF’s FA Score shows that 1 FA rating(s) are green whileLYPHF’s FA Score has 0 green FA rating(s).

  • JCRRF’s FA Score: 1 green, 4 red.
  • LYPHF’s FA Score: 0 green, 5 red.
According to our system of comparison, JCRRF is a better buy in the long-term than LYPHF.

Price Growth

JCRRF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while LYPHF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.89%. For the same industry, the average monthly price growth was +1.22%, and the average quarterly price growth was +11.81%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.15%. For the same industry, the average monthly price growth was +68.06%, and the average quarterly price growth was +81.85%.

Industries' Descriptions

@Pharmaceuticals: Major (-1.89% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Pharmaceuticals: Generic (+1.15% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

FUNDAMENTALS
Fundamentals
LYPHF($1.67B) has a higher market cap than JCRRF($501M). JCRRF has higher P/E ratio than LYPHF: JCRRF (20.45) vs LYPHF (15.33). JCRRF YTD gains are higher at: 9.409 vs. LYPHF (-22.025).
JCRRFLYPHFJCRRF / LYPHF
Capitalization501M1.67B30%
EBITDA3.21BN/A-
Gain YTD9.409-22.025-43%
P/E Ratio20.4515.33133%
Revenue35.3BN/A-
Total Cash18.3BN/A-
Total Debt28.4BN/A-
TECHNICAL ANALYSIS
Technical Analysis
JCRRFLYPHF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
7%
Bullish Trend 1 day ago
5%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
6%
Bullish Trend 1 day ago
5%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DILAX15.550.06
+0.39%
Davis International A
AEYIX9.06N/A
N/A
American Century Equity Income C
HSCYX30.00N/A
N/A
Hartford Small Company Y
AMRBX4.73N/A
N/A
American Growth One B
TEMSX9.11N/A
N/A
Nuveen Emerging Markets Eq Retiremt

JCRRF and

Correlation & Price change

A.I.dvisor tells us that JCRRF and SNYNF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JCRRF and SNYNF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JCRRF
1D Price
Change %
JCRRF100%
N/A
SNYNF - JCRRF
8%
Poorly correlated
N/A
SCLX - JCRRF
4%
Poorly correlated
+1.17%
MIRA - JCRRF
2%
Poorly correlated
+2.19%
CSWYF - JCRRF
0%
Poorly correlated
N/A
VRBCF - JCRRF
-0%
Poorly correlated
N/A
More

LYPHF and

Correlation & Price change

A.I.dvisor tells us that LYPHF and OGN have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LYPHF and OGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYPHF
1D Price
Change %
LYPHF100%
N/A
OGN - LYPHF
4%
Poorly correlated
-0.22%
SNYNF - LYPHF
3%
Poorly correlated
N/A
CSWYF - LYPHF
1%
Poorly correlated
N/A
VRBCF - LYPHF
-0%
Poorly correlated
N/A
JCRRF - LYPHF
-1%
Poorly correlated
N/A
More